Physician Ability to Assess Rheumatoid Arthritis Disease Activity Using an Electronic Medical Record-Based Disease Activity Calculator

被引:10
|
作者
Collier, Deborah S. [1 ,2 ]
Grant, Richard W. [2 ]
Estey, Greg
Surrao, Dominic
Chueh, Henry C. [2 ]
Kay, Jonathan [2 ]
机构
[1] Massachusetts Gen Hosp, Yawkey Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源
关键词
COLLEGE-OF-RHEUMATOLOGY; RANDOMIZED CONTROLLED-TRIAL; ACTIVITY SCORE; CLINICAL-PRACTICE; IMPROVEMENT CRITERIA; ACTIVITY INDEX; JOINT COUNTS; VALIDATION; METHOTREXATE; COMBINATION;
D O I
10.1002/art.24335
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess physicians' concordance with Disease Activity Score in 28 joints (DAS28) categories calculated by an electronic medical record (EMR)-embedded disease activity calculator, as well as attitudes toward this application. Methods. Fifteen rheumatologists used the EMR-embedded disease activity calculator to predict a rheumatoid arthritis (RA) DAS28 disease activity category at the time of each clinical encounter. Results. physician-predicted DAS28 disease activity categories ranged from high (> 5.1, 15% of cohort, 66 of 429 patient visits) to moderate (>3.2-5.1, 21% of cohort, 90 of 429 patient visits) to low (2.6-3.2, 29% of cohort, 123 of 429 patient visits) to remission (<2.6, 35% of cohort, 150 of 429 patient visits). Overall concordance between calculated DAS28 results and physician-predicted RA disease activity was 64%. Using either the physician-predicted or the calculated DAS28 category as the gold standard, accuracy was greatest for patients in remission (75% and 88% accuracy, respectively) and those with high disease activity (68% and 79% accuracy, respectively), and less for patients with moderate (48% and 62% accuracy, respectively) or low disease activity (62% and 31% accuracy, respectively). Conclusion. Accurate physician prediction of DAS28 remission and high disease activity categories, even without immediate availability of the erythrocyte sedimentation rate or the C-reactive protein level at the time of the visit, may be used to guide quantitatively driven outpatient RA management.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 50 条
  • [31] PHYSICIAN GLOBAL ASSESSMENTS FOR DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS ARE ALL OVER THE MAP!
    Turk, M. A.
    Pope, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 854 - 855
  • [32] Measuring disease activity for rheumatoid arthritis
    Aletaha, D
    Stamm, T
    Smolen, J
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2006, 65 (02): : 93 - +
  • [33] Disease activity measures for rheumatoid arthritis
    Dougados, M.
    Aletaha, D.
    van Riel, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (05) : S22 - S29
  • [34] Measures of Rheumatoid Arthritis Disease Activity
    Johnson, Tate M.
    Michaud, Kaleb
    England, Bryant R.
    ARTHRITIS CARE & RESEARCH, 2020, 72 : 4 - 26
  • [35] Measures of Rheumatoid Arthritis Disease Activity
    Kirwan, John
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 442 - 443
  • [36] The assessment of disease activity in rheumatoid arthritis
    Smolen, J. S.
    Aletaha, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (03) : S18 - S27
  • [37] Quantification of morning stiffness to assess disease activity and treatment effects in rheumatoid arthritis
    Boeth, Heide
    Biesen, Robert
    Hollnagel, Jeremias
    Herrmann, Sandra
    Ehrig, Rainald M.
    Pelli, Lorenzo
    Taylor, William R.
    Duda, Georg N.
    Buttgereit, Frank
    RHEUMATOLOGY, 2021, 60 (11) : 5282 - 5291
  • [38] THE USE OF MUSCULOSKELETAL ULTRASOUND TO ASSESS DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: A FEASIBILITY EXERCISE
    Dale, James
    Gupta, Monica
    Porter, Duncan
    RHEUMATOLOGY, 2009, 48 : I131 - I131
  • [39] Cold Agglutinin Disease Transfusion Practices in the United States: An Electronic Medical Record-Based Analysis
    Su, Jun
    Punekar, Rajeshwari
    Arias, Jaime Morales
    Jain, Nisha
    BLOOD, 2019, 134
  • [40] KNEE EXTENSOR STRENGTH AND DISEASE ACTIVITY AFFECT WALKING ABILITY IN RHEUMATOID ARTHRITIS
    Ito, H.
    Morita, Y.
    Hashimoto, M.
    Tanaka, M.
    Azukizawa, M.
    Mimori, T.
    Matsuda, S.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S58 - S59